This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Life Sciences Research Partners Vzw. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Kathleen Freson: Innovator in Thrombocytopenia Treatment
Introduction
Kathleen Freson is a prominent inventor based in Heverlee, Belgium. She has made significant contributions to the field of medical research, particularly in the area of thrombocytopenia, a condition characterized by low blood platelet counts. Her innovative work has the potential to impact the treatment and prevention of this condition.
Latest Patents
Kathleen Freson holds a patent for the invention titled "Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia." This patent discloses the use of inhibitors and/or antagonists of PACAP signalling for the manufacture of a medicament aimed at preventing or treating decreased blood platelet numbers.
Career Highlights
Kathleen is associated with Life Sciences Research Partners Vzw, where she continues to advance her research and innovations. Her work is recognized for its potential to improve patient outcomes in the treatment of thrombocytopenia.
Collaborations
She has collaborated with notable colleagues, including Chris Van Geet and Marc Hoylaerts, who share her commitment to advancing medical science and improving therapeutic options for patients.
Conclusion
Kathleen Freson is a dedicated inventor whose work in thrombocytopenia treatment exemplifies the impact of innovative research in medicine. Her contributions are paving the way for new therapeutic approaches that could benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile